Peptide V3 Inhibits the Growth of Human Hepatocellular Carcinoma by Inhibiting the Ras/Raf/MEK/ERK Signaling Pathway

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths. Peptide V3 has shown anti-angiogenic and anti-tumor effects on S180 and H22 xenografts in nude mice. However, the detailed mechanism of action of peptide V3 has not yet been fully elucidated. In the present study,...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Cancer
Päätekijät: Wu, Dongdong, Li, Mengling, Gao, Yingran, Tian, Wenke, Li, Jianmei, Zhang, Qianqian, Liu, Zhengguo, Zheng, Mengli, Wang, Hongju, Wang, Jun, Teng, Tieshan, Zhang, Lei, Ji, Xinying, Xie, Zhongwen, Ji, Ailing, Li, Yanzhang
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Ivyspring International Publisher 2019
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6548006/
https://ncbi.nlm.nih.gov/pubmed/31205525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.29211
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia